MedPath

Neural Mechanisms of Cognitive Assessment and Rehabilitation for Cognitive Decline

Not Applicable
Recruiting
Conditions
Mild Cognitive Impairment (MCI)
Aging
Subjective Cognitive Decline (SCD)
Healthy
Interventions
Combination Product: multi-modal targeted intervention (e.g., cognitive training, exercise, games)
Registration Number
NCT05014893
Lead Sponsor
National Research Center for Rehabilitation Technical Aids
Brief Summary

This study investigates the neural mechanisms of cognitive function decline, cognitive assessment methods for subjects with mild cognitive dysfunction (Mild cognitive impairment, MCI, or cognitive decline milder than MCI), and the approaches used to improve and restore cognitive function.

Detailed Description

Cognitive assessment tools are used to assess cognitive function of subjects in different cities. Functional and structural MRI and EEG are applied to investigate the neural mechanisms of cognitive function decline and effects of methods to improve and restore cognitive function.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Adults being able to walk at least a block, and
  • Adults with subjective cognitive decline (SCD), or
  • Adults with mild cognitive impairment (MCI), or
  • Adults with normal cognitive function
Exclusion Criteria
  • Clinical diagnosis of dementia
  • Adults who cannot follow the protocal

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cognitive trainingmulti-modal targeted intervention (e.g., cognitive training, exercise, games)This group receives treatments to improve cognitive function.
Primary Outcome Measures
NameTimeMethod
Change in Cognitive function (MoCA)Change from Baseline Cognitive test results at 3 months.

The Montreal Cognitive Assessment test is used to assess cognitive function of participants.

Change in Cognitive function (AD8)Change from Baseline Cognitive test results at 3 months.

The AD8 test is used to assess cognitive function of participants.

Change in Cognitive function (CDR)Change from Baseline Cognitive test results at 3 months.

The Clinical Dementia Rating (CDR) test is used to assess cognitive function of participants.

Change in Cognitive function (SCD-9)Change from Baseline Cognitive test results at 3 months.

The SCD-9 questionnaire is used to assess cognitive function of participants.

Secondary Outcome Measures
NameTimeMethod
Change in Physical capacity (TUG)Change from Baseline physical capacity test results at 3 months.

The timed up and go (TUG) test is used to evaluate physical capacity of participants.

Change in Physical capacity (chair standing)Change from Baseline physical capacity test results at 3 months.

The 30-second chair standing test is used to evaluate physical capacity of participants.

Trial Locations

Locations (1)

National Research Center for Rehabilitation Technical Aids

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath